Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Vertex Pharmaceuticals logoVertex Pharmaceuticals VRTX

Vertex said at its annual meeting on May 14, 2025 that Sangeeta Bhatia, Lloyd Carney, Alan Garber and others were elected to serve on its Board of Directors until the annual meeting in 2026.

8-KSubmission of Matters to a Vote of Security HoldersFiled Period of report Summary published (UTC)

Key points

AI summary
  1. Vertex said at its annual meeting on May 14, 2025 that Sangeeta Bhatia, Lloyd Carney, Alan Garber and others were elected to serve on its Board of Directors until the annual meeting in 2026.

  2. The company said Reshma Kewalramani received 225,606,258 votes in favor in the director election, while Bruce Sachs received 211,582,895 votes in favor and 14,580,875 votes against.

  3. The company said shareholders approved the appointment of Ernst & Young LLP as its independent registered public accounting firm for the year ending December 31, 2025 with 229,386,037 votes in favor, and approved on an advisory basis the 2024 executive compensation program with 208,886,386 votes in favor.

  4. The company said a shareholder proposal on excessive golden parachutes was not approved, with 84,117,100 votes in favor and 141,606,344 votes against.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Annual Meeting Director Election Results

Vertex said at its annual meeting on May 14, 2025 that Sangeeta Bhatia, Lloyd Carney, Alan Garber and others were elected to serve on its Board of Directors until the annual meeting in 2026.

Source · Based on the filing body and exhibits

Director Election Voting Results

The company said Reshma Kewalramani received 225,606,258 votes in favor in the director election, while Bruce Sachs received 211,582,895 votes in favor and 14,580,875 votes against.

Source · Based on the filing body and exhibits

Auditor Appointment and Compensation Advisory Vote

The company said shareholders approved the appointment of Ernst & Young LLP as its independent registered public accounting firm for the year ending December 31, 2025 with 229,386,037 votes in favor, and approved on an advisory basis the 2024 executive compensation program with 208,886,386 votes in favor.

Source · Based on the filing body and exhibits

Shareholder Proposal on Golden Parachutes Not Approved

The company said a shareholder proposal on excessive golden parachutes was not approved, with 84,117,100 votes in favor and 141,606,344 votes against.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.